Point72 Hong Kong’s Thermo Fisher Scientific TMO Stock Holding History

Point72 Hong Kong’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$7.04M	Buy	14,524 +4,149	+40%	+$1.93M	0.32%	59
2025 Q2	$4.21M	Buy	+10,375	New	+$4.34M	0.27%	86
2024 Q3	–	Sell	-56,451	Closed	-$31.2M	–	642
2024 Q2	$31.2M	Buy	56,451 +40,226	+248%	+$23M	1.87%	11
2024 Q1	$9.43M	Buy	+16,225	New	+$9.1M	0.47%	55
2022 Q4	–	Sell	-31,601	Closed	-$16M	–	1538
2022 Q3	$16M	Buy	31,601 +15,586	+97%	+$8.72M	0.56%	20
2022 Q2	$8.7M	Buy	+16,015	New	+$8.82M	0.32%	57
2022 Q1	–	Sell	-28	Closed	-$16.1K	–	2316
2021 Q4	$19K	Sell	28 -2,070	-99%	-$1.29M	﹤0.01%	1547
2021 Q3	$1.2M	Buy	+2,098	New	+$1.15M	0.04%	674
2021 Q2	–	Sell	-20,337	Closed	-$9.6M	–	2353
2021 Q1	$9.28M	Buy	20,337 +13,073	+180%	+$6.24M	0.31%	36
2020 Q4	$3.38M	Buy	+7,264	New	+$3.41M	0.15%	144
2020 Q2	–	Sell	-1,043	Closed	-$296K	–	1424
2020 Q1	$296K	Buy	+1,043	New	+$329K	0.13%	57
2017 Q1	–	Sell	-100	Closed	-$14K	–	976
2016 Q4	$14K	Sell	100 -2,200	-96%	-$324K	0.01%	603
2016 Q3	$366K	Buy	+2,300	New	+$354K	0.2%	134

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Point72 Hong Kong's TMO Position: Q3 2025 in Review

Point72 Hong Kong increased its Thermo Fisher Scientific (TMO) stake by 40% in Q3 2025, buying an estimated $1.93M and bringing the position to 14,524 shares worth $7.04M. The position accounts for 0.32% of the portfolio, ranked #59.

Point72 Hong Kong first reported a position in TMO in Q3 2016 and has held it in 13 quarters since. The position peaked at $31.2M in Q2 2024. 2,509 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

Point72 Hong Kong held 14,524 shares of Thermo Fisher Scientific worth $7.04M as of Q3 2025.
Point72 Hong Kong bought 4,149 Thermo Fisher Scientific shares in Q3 2025, an estimated $1.93M.
Thermo Fisher Scientific made up 0.32% of Point72 Hong Kong's portfolio in Q3 2025, its #59 holding.
Point72 Hong Kong first reported a position in Thermo Fisher Scientific in Q3 2016 and has held it in 13 quarters since.
Point72 Hong Kong's Thermo Fisher Scientific position peaked at $31.2M in Q2 2024.
2,509 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.